Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (4)
- Public Health (4)
- Infectious Disease (3)
- Life Sciences (3)
- Biology (2)
-
- Chemical Actions and Uses (2)
- Chemicals and Drugs (2)
- Engineering (2)
- Environmental Public Health (2)
- Immune System Diseases (2)
- Skin and Connective Tissue Diseases (2)
- Acoustics, Dynamics, and Controls (1)
- Amino Acids, Peptides, and Proteins (1)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Anatomy (1)
- Biochemistry (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Clinical and Medical Social Work (1)
- Communication Sciences and Disorders (1)
- Community Health and Preventive Medicine (1)
- Critical Care (1)
- Dermatology (1)
- Digestive System Diseases (1)
- Disease Modeling (1)
- Early Childhood Education (1)
- Education (1)
- Emergency Medicine (1)
- Institution
- Keyword
-
- Covid-19 (2)
- Virus (2)
- ACH (Air exchanges per hour) (1)
- Air handling unit (1)
- Antimicrobial Resistance, Natural Products, Regulatory Proteins, Elicitors, Machine Learning, Drug Discovery (1)
-
- COVID-19 (1)
- COVID-19 pandemic (1)
- Clean air (1)
- Computational Fluid Dynamics (1)
- Decontaminate air (1)
- Decontamination (1)
- Ducts and vents (1)
- Fresh air (1)
- HIV Testing (1)
- HVAC (1)
- HVAC-R (1)
- Harm Reduction (1)
- Harm Reduction Counseling (1)
- Health Equity (1)
- Indoor air Quality (1)
- Indoor air quality (1)
- Lower Extremity (1)
- Muscle Weakness (1)
- Myositis (1)
- Outbreaks (1)
- Paraparesis (1)
- Post-COVID Conditions (1)
- Real solutions (1)
- Sars-Cov-2 (1)
- Solutions to covid (1)
- Publication
- Publication Type
Articles 1 - 10 of 10
Full-Text Articles in Virus Diseases
Testing Elicitors Of Homologous Jadr2 Proteins To Regulate Natural Product Production, Carzon J. Williams, Emilee A. Patterson, Allison S. Walker
Testing Elicitors Of Homologous Jadr2 Proteins To Regulate Natural Product Production, Carzon J. Williams, Emilee A. Patterson, Allison S. Walker
SPARK Symposium Presentations
The growing threat of antimicrobial resistance (AMR) has and will contribute to global economic and public health concerns in the foreseeable future leading into 2050. As mortality rates derived from AMR are projected to reach 10 million if no viable solution is found to combat it through hastened drug discovery. The use of natural products to mitigate AMRs effects is viable as more than 50% of FDA approved drugs are natural products. These natural products are synthesized by biosynthetic gene clusters (BGC), found in bacteria with a regulatory protein not allowing transcription until unbound . Current methods of eliciting the …
Skin Manifestations In People With Hepatitis C, Erjola Toska, Cameron Minars, Suzanne Riskin
Skin Manifestations In People With Hepatitis C, Erjola Toska, Cameron Minars, Suzanne Riskin
HCA-NSU MD Research Day
Skin Manifestations in People with Hepatitis C Authors: Erjola Toska, OMS-III, Cameron Minars, OMS-II, Suzanne Riskin, M.D. Objectives: This study is aimed to summarize the association between hepatitis C infection and dermatological manifestations from the past decade. Background: Hepatitis C is a growing global health concern, with rising incidence rates and an increased likelihood of extrahepatic manifestations, including dermatological conditions. Despite research into the connection between hepatitis C and skin disorders, there is a lack of comprehensive reviews on this subject. Methods: Four databases—PubMed (NLM), EMBASE, CINAHL, and Web of Science—were searched for peer-reviewed articles written in English, focusing on …
Lower Extremity Weakness In The Setting Of Covid Myositis, Christopher Dellmyer, Frank Wheeler
Lower Extremity Weakness In The Setting Of Covid Myositis, Christopher Dellmyer, Frank Wheeler
Rowan-Virtua Research Day
Bilateral lower extremity weakness has numerable causes including stroke, peripheral neuropathy, deconditioning, Guillain-Barre, Multiple Sclerosis, anterior cord syndrome, trauma, spinal epidural abscess and many more. It is imperative however, that we investigate and understand more rare causes of lower extremity weakness. Here we present the case of a 74-year-old female presented to the ED with a complaint of lower extremity weakness due to Covid myositis causing significant bilateral lower extremity weakness.
A Novel Approach To Hiv Testing: Group Harm Reduction And Testing For High Risk Women In Nj, Gabrianna A. Andrews
A Novel Approach To Hiv Testing: Group Harm Reduction And Testing For High Risk Women In Nj, Gabrianna A. Andrews
Rowan-Virtua Research Day
Outreach programs have been implemented aimed at providing healthcare to minority populations and those considered high-risk for acquiring HIV. Variables such as these cause hesitance in community members, preventing HIV screenings and adherence to follow-ups. This study provides and evaluates a new approach: group HIV testing. Data was collected from 6/2/2023 to 4/19/2024 by surveying participants at the end of the interaction. 87.5% of participants rated their care at the mobile clinic as ‘Excellent’, 8% as ‘Very Good’, and 4.5% as ‘Good’. 95.6% of participants ranked Group Harm Reduction Counseling as ‘Definitely’ helpful. 84.4% of participants did not find that …
Post-Intensive Care Syndrome Prevention And Detection In Covid-19 Patients, Bethany Sloane Melega
Post-Intensive Care Syndrome Prevention And Detection In Covid-19 Patients, Bethany Sloane Melega
Student Scholar Showcase
COVID-19 has impacts on patient health beyond the hospital. The trauma that patients, and families of patients, can experience during an admission to an intensive care unit (ICU) can last long after discharge from the ICU and the hospital in general. The psychological and physical impacts of ICU hospitalization can cause patients to experience Post Intensive Care Syndrome (PICS). PICS is the culmination of symptoms that persist after a critical illness that involve all aspects of a patient’s physical and mental well-being and can significantly affect family life and increase recovery time. Due to the strict personal-protective equipment (PPE) usage …
Understanding Of Aerosol Transmission Of Covid 19 In Indoor Environment - Part 2: Approaches To Mitigation, Adama Barro, Cathal O'Toole, Jacob S. Lopez, Matthew Quinones, Sherene Moore
Understanding Of Aerosol Transmission Of Covid 19 In Indoor Environment - Part 2: Approaches To Mitigation, Adama Barro, Cathal O'Toole, Jacob S. Lopez, Matthew Quinones, Sherene Moore
Publications and Research
The challenge we face in implementing solutions for new HVAC ventilation and filtration design, is to effectively improve air quality for virus mitigation without losing performance efficiency. The purpose of this improvement is to decontaminate the occupied enclosed areas, reducing the transmission of the corona virus aerosol transmission. Our research seeks reliable approaches to mitigate the further spread of aerosol transmission in indoor spaces. The methodology is to examine innovative HVAC engineering solutions that combat epidemiological problems of Covid-19 for the post-pandemic era, by researching scholarly articles and ASHRAE journals. We are achieving the goal of finding highly efficient resolutions …
Understanding Of Aerosol Transmission Of Covid 19 In Indoor Environments, Adama Barro, Cathal O'Toole, Jacob S. Lopez, Matthew Quinones, Sherene Moore
Understanding Of Aerosol Transmission Of Covid 19 In Indoor Environments, Adama Barro, Cathal O'Toole, Jacob S. Lopez, Matthew Quinones, Sherene Moore
Publications and Research
Our reason for discussing severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) or 2019 novel corona virus (Covid-19), is to understand its aerosol transmission characteristics in indoor spaces and to mitigate further spread of this disease by designing a new HVAC system. The problem that we are tackling is the spread of covid-19 droplets through aerosol transmission by looking at potential engineering solutions to the existing HVAC systems. The purpose is to eradicate the spread of the COVID-19 by testing indoor spaces in an effort to understand the effectiveness of ventilation controls. We believe that scientists and engineers have not …
Fact Or Myth: The Flu Can Be Caused By The Flu Vaccine, Arleigh Wood
Fact Or Myth: The Flu Can Be Caused By The Flu Vaccine, Arleigh Wood
Virtual 2020 Spring Student Showcase for Research and Creative Inquiry
To many, the flu vaccine seems like a threat to an otherwise healthy individual. People often get the flu after receiving the flu shot, which does not promote confidence in the general public. These and other reasonings have created a myth that the flu vaccine can cause the flu. Understanding how the vaccination is created and how it interacts with the immune system helps to realize why the flu vaccine cannot cause the virus. For the vaccine to work, adaptive immunity must be activated by the introduction of the viral particles in a safe manner. An effective immune response from …
Don't Bug Me: Everything Young Kids Need To Know About Coronavirus--In Verse!, Rhea Paul
Don't Bug Me: Everything Young Kids Need To Know About Coronavirus--In Verse!, Rhea Paul
Community Reflections
A story in verse for young children (3-8) about coronavirus. Narrated by the author, Rhea Paul. Press the "Slide Show" button at the top of the screen, then in the menu that appears, hit "Play from Beginning" all the way to the left.
Studies Of Amino Acid Mutations In Drug Resistance Of The Smo Protein, Eunice Wintona
Studies Of Amino Acid Mutations In Drug Resistance Of The Smo Protein, Eunice Wintona
UNO Student Research and Creative Activity Fair
Smoothened receptor (SMO) is a protein that in humans, is encoded by the SMO gene. A systemic mutation in its binding pocket helps predict the sensitivity of mutant proteins to different drugs. Known as a GPCR-like receptor, it is a component of the hedgehog signaling pathway; a pathway involved in body patterning and the regulation of adult stem cells. An uncontrolled or inappropriate activation of the Hedgehog pathway drives tumor progression in cancers and a number of birth defects. To achieve these goals, the molecular modeling software MOE was used to build small molecules and drug molecules like Vismodegib and …